📅 Last week in GLP1 (2026/08/24)
The latest GLP1 news and research you should know about.
GLP1 Guide
The latest research and information on GLP1 Receptor Agonists (Ozempic, Wegovy, Mounjaro, Zepbound , etc) and their effects on type 2 diabetes, weight loss, and heart disease.
Live Last read · last published · next check
Latest posts
📅 Last week in GLP1 (2026/08/17)
The latest GLP1 news and research you should know about.
📅 Last week in GLP1 (2026/08/10)
The latest GLP1 news and research you should know about.
📅 Last week in GLP1 (2026/08/03)
The latest GLP1 news and research you should know about.
🚨 Australia adds warning labels to GLP1s for NAION (blinding disease)
The risk of vision disorders on GLP1s may be rare, but the evidence is clear.
🌊 The GLP1 wave continues to pitch and roll
More people and corporations rely on GLP1s, despite some curbs in the public sector
📅 Last week in GLP1 (2026/07/27)
The latest GLP1 news and research you should know about.
☀️ Slow summer? Not in GLP1 land
A recap of ongoing and breaking GLP1 stories this summer
📅 Last week in GLP1 (2026/07/20)
The latest GLP1 news and research you should know about.
📅 Last week in GLP1 (2026/07/13)
The latest GLP1 news and research you should know about.
🧬 How is GLP1 gene therapy progressing?
We check in on the promising technology and the companies pursuing it